hemotrop
mycoplasma
hemoplasma
cellwal
free
bacteria
attach
red
blood
cell
potenti
induc
hemolyt
anemia
domest
cat
least
three
felin
hemotrop
mycoplasma
speci
known
mycoplasma
haemof
haemof
candidatu
mycoplasma
haemominutum
cand
haemominutum
candidatu
mycoplasma
turicensi
cand
turicensi
pathogen
potenti
significantli
vari
among
three
felin
speci
haemof
pathogen
three
speci
acut
infect
often
result
hemolyt
anemia
diagnosi
felin
hemotrop
mycoplasma
infect
reli
detect
differenti
infecti
agent
sensit
specif
polymeras
chain
reaction
pcr
quantifi
humor
immun
respons
felin
hemoplasma
enzymelink
immunosorb
assay
elisa
base
recombin
haemof
dnak
protein
develop
recombin
haemof
protein
recogn
antibodi
haemof
lesser
degre
antibodi
cand
turicensi
cand
haemominutum
observ
crossreact
humor
immun
respons
led
assumpt
potenti
crossprotect
among
three
hemoplasma
infect
recent
studi
high
level
antibodi
detect
cat
experiment
infect
cand
turicensi
even
month
infect
bacteremia
clear
cand
turicensi
pcrneg
seroposit
cat
also
protect
subsequ
cand
turicensi
challeng
similarli
cat
overcom
haemof
bacteremia
pcrneg
serolog
posit
haemof
subsequ
protect
second
haemof
bacteremia
reexposur
limit
inform
avail
concern
potenti
crossprotect
infect
differ
felin
hemoplasma
speci
natur
infect
cat
wildcat
dual
tripl
infect
haemof
cand
haemominutum
cand
turicensi
report
howev
natur
infect
typic
determin
infect
simultan
sequenti
acquir
crossprotect
might
expect
infect
sequenti
acquir
effici
immun
respons
rais
experiment
coinfect
demonstr
earli
infect
studi
use
socal
larg
small
haemobartonella
feli
strain
howev
cat
clear
primari
infect
superinfect
second
hemoplasma
strain
thu
crossprotect
observ
vaccin
approach
involv
attenu
organ
may
offer
hemoplasma
protect
cand
turicensi
much
less
pathogen
haemof
thu
cand
turicensi
would
ideal
candid
attenu
haemof
vaccin
crossprotect
haemof
exposur
found
cat
develop
immun
cand
turicensi
thu
aim
present
studi
investig
potenti
crossprotect
haemof
cat
overcom
previou
cand
turicensi
infect
character
cours
infect
cand
turicensi
recov
cat
analyz
hematolog
clinic
chemistri
paramet
lymphocyt
subset
cytokin
transcript
level
hemoplasma
shed
pattern
ten
adult
male
specifi
pathogenfre
spf
cat
liberti
research
waverli
ny
usa
includ
present
studi
cat
assign
two
group
group
compris
five
cat
previous
experienc
experiment
cand
turicensi
lowdos
infect
describ
detail
elsewher
group
b
compris
five
spf
cat
cat
group
list
previou
studi
prior
start
experi
cat
group
overcom
acut
cand
turicensi
infect
bacteremia
pcrneg
serolog
posit
detail
descript
pcr
serolog
see
cat
group
five
year
old
wherea
group
b
three
cat
three
year
old
two
cat
six
year
old
cat
castrat
prior
experi
experi
perform
accord
swiss
law
offici
approv
veterinari
offic
canton
zurich
tvb
cat
kept
two
separ
group
confin
univers
facil
barrier
condit
optim
etholog
hygien
condit
previous
describ
prior
start
experi
cat
clinic
examin
spf
statu
cat
verifi
test
absenc
infect
felin
hemoplasma
parvoviru
caliciviru
coronaviru
leukemia
immunodefici
viru
bartonella
hensela
chlamydophila
feli
use
sampl
procedur
method
previous
describ
cat
subject
lowdos
haemof
exposur
day
previous
describ
detail
see
edtaanticoagul
blood
serum
sampl
collect
pcr
hematolog
clinic
chemistri
serolog
analys
day
haemof
exposur
time
point
see
figur
addit
file
monitor
haemof
shed
saliva
rectal
swab
collect
time
point
indic
figur
day
use
commerci
avail
cotton
swab
previous
describ
urin
sampl
collect
cat
cystocentesi
one
day
prior
day
haemof
exposur
day
cat
group
urinalysi
perform
urin
sediment
evalu
use
standard
procedur
clinic
condit
bodi
temperatur
bodi
weight
record
sampl
time
point
haemofelisinfect
cat
develop
sever
anemia
hematocrit
andor
poor
gener
condit
treat
doxycyclin
oral
mgkgd
gmbh
switzerland
day
prednisolon
oral
mgkg
everi
h
gradual
withdrawn
streuli
pharma
ag
uznach
switzerland
ten
day
fluid
therapi
ringer
lactat
solut
freseniu
kabi
schweiz
ag
stan
switzerland
see
also
figur
haemof
lowdos
infect
model
previous
describ
briefli
heparin
infecti
blood
cat
preserv
dimethylsulfoxid
volvol
liquid
nitrogen
use
prepar
inoculum
blood
sampl
thaw
dilut
cold
phosphatebuff
salin
pb
final
concentr
copi
determin
specif
rrna
realtim
qpcr
inoculum
maintain
ice
cat
subcutan
inject
inoculum
region
neck
within
five
minut
dilut
inoculum
white
blood
cell
differenti
complet
hemogram
perform
use
sysmex
sysmex
corpor
kobe
japan
hematocrit
consid
within
refer
rang
anemia
defin
hematocrit
valu
leukopenia
defin
neutropenia
defin
hematolog
refer
rang
determin
use
ident
method
blood
sampl
clinic
healthi
cat
previou
studi
demonstr
antibodi
direct
erythrocyt
surfac
haemofelisinfect
cat
coomb
test
perform
coomb
test
perform
toward
end
studi
day
post
haemof
exposur
previous
describ
follow
modif
felin
antiglobulin
coomb
reagent
mp
biomed
solon
ohio
usa
serial
dilut
serum
chemistri
perform
use
coba
integra
system
roch
diagnost
rotkreuz
switzerland
includ
laboratori
standard
felin
clinic
chemistri
panel
bilirubin
glucos
blood
urea
nitrogen
bun
creatinin
protein
albumin
cholesterol
triglycerid
alkalin
phosphatas
amylas
aspart
aminotransferas
alanin
aminotransferas
lipas
sodium
chlorid
potassium
calcium
phosphat
globulin
valu
calcul
subtract
albumin
total
protein
concentr
refer
rang
state
quantil
determin
routin
purpos
use
ident
method
blood
sampl
clinic
healthi
cat
serum
protein
electrophoresi
perform
day
prior
day
post
haemof
exposur
semiautom
agaros
gel
electrophoresi
system
hydragelhydrasi
sebia
pn
issyl
moulineaux
franc
use
accord
manufactur
instruct
hydragel
protein
kit
sebia
pn
refer
rang
determin
routin
purpos
use
ident
method
serum
sampl
clinic
healthi
cat
state
quantil
total
nucleic
acid
tna
extract
edtaanticoagul
blood
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
previous
describ
saliva
rectal
swab
incub
pb
min
prior
tna
extract
previous
describ
tna
extract
urin
use
magna
pure
lc
dna
isol
kit
iii
bacteria
fungi
roch
diagnost
preisol
step
bacteri
lysi
buffer
proteinas
k
ad
mixtur
incub
min
subsequ
procedur
perform
accord
manufactur
instruct
tna
elut
elut
buffer
store
use
nucleic
acid
extract
neg
control
pb
concurr
prepar
batch
sampl
monitor
crosscontamin
tna
sampl
test
use
realtim
qpcr
presenc
quantiti
haemof
cand
turicensi
abi
prism
sequenc
detect
system
appli
biosystem
rotkreuz
switzerland
serial
dilut
plasmid
standard
previous
describ
pcr
reaction
posit
plasmid
standard
neg
control
nucleas
free
water
includ
assay
antibodi
haemof
cand
turicensi
measur
use
elisa
base
recombin
haemof
dnak
protein
previous
describ
serum
dilut
signaltonois
ratio
calcul
divid
post
preinfect
absorb
valu
individu
cat
previous
describ
elisa
signal
ratio
consid
serolog
posit
sampl
collect
day
post
haemof
exposur
includ
measur
blood
sampl
cytokin
transcript
analysi
collect
day
post
haemof
exposur
one
hundr
microlit
edtaanticoagul
blood
collect
immedi
mix
mrna
lysi
buffer
mrna
isol
kit
roch
diagnost
sampl
store
within
h
collect
mrna
purifi
use
mrna
isol
kit
magna
pure
lc
instrument
roch
diagnost
accord
manufactur
instruct
mrna
elut
elut
buffer
store
use
firststrand
cdna
synthes
use
high
capac
cdna
revers
transcript
kit
appli
biosystem
accord
manufactur
instruct
mrna
sampl
cdna
synthes
duplic
pool
cdna
sampl
store
use
realtim
pcr
assay
perform
rel
quantif
felin
interleukin
il
tumor
necrosi
use
primer
probe
previous
describ
primer
probe
design
revers
primer
anneal
exonexon
junction
reaction
contain
forward
revers
primer
probe
cytokin
assay
run
use
fast
univers
pcr
master
mix
initi
denatur
follow
cycl
transcript
level
vabl
abelson
murin
leukemia
viral
oncogen
homolog
abl
zeta
polypeptid
ywhaz
gene
serv
refer
normal
describ
two
gene
found
best
quantit
analysi
felin
blood
sampl
pcr
assay
perform
use
rotorgen
realtim
rotari
analyz
corbett
mortlak
australia
calcul
mrna
express
level
ctvalu
effici
cytokin
refer
gene
assay
perform
use
genorm
version
briefli
cytokin
transcript
level
normal
transcript
level
abl
ywhaz
time
point
use
calcul
rel
transcript
level
compar
day
edtaanticoagul
blood
sampl
flow
cytometri
collect
day
prior
haemof
exposur
day
haemof
exposur
process
previous
describ
follow
antibodi
combin
use
fluorescein
isothiocyan
fitc
conjug
mous
antifelin
antibodi
southern
biotech
bioconcept
allschwil
switzerland
recogn
lymphocyt
unconjug
mous
antifelin
mhcii
antibodi
vmrd
qiagen
leipzig
germani
rphycoerythrin
rpe
conjug
mous
antifelin
antibodi
abd
serotec
puchheim
germani
fluorescein
isothiocyan
fitc
conjug
mous
antifelin
antibodi
kindli
provid
mb
tompkin
g
dean
unconjug
mous
antifelin
antibodi
southern
biotech
peridinin
chlorophylla
protein
percp
conjug
rat
antimous
antibodi
bd
bioscienc
allschwil
switzerland
allophycocyanin
apc
conjug
mous
antibodi
bd
bioscienc
rpegoat
antimous
mhcii
antibodi
southern
biotech
use
secondari
antibodi
aliquot
blood
cat
left
unstain
neg
control
flow
cytometri
perform
use
bd
platform
bd
bioscienc
softwar
forward
revers
scatter
gate
set
lymphocyt
popul
event
acquir
sampl
lymphocyt
subset
calcul
product
absolut
lymphocyt
number
determin
hematolog
subset
percentag
determin
flow
cytometri
previous
describ
number
cat
per
experiment
group
five
kept
minimum
anim
welfar
reason
time
five
anim
per
group
necessari
potenti
reach
statist
signific
group
even
one
cat
result
one
cat
per
group
lost
unforese
reason
statist
analys
perform
use
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
nonparametr
test
paramet
compar
two
group
use
utest
pmwu
wilcoxon
signedrank
test
pw
use
compar
serum
protein
electrophoresi
result
cat
two
differ
time
point
friedman
test
pf
follow
dunn
post
test
use
analyz
paramet
time
two
time
point
consid
multipl
adjust
pvalu
comparison
famili
comparison
comput
correl
analys
spearman
rank
correl
test
use
ps
correl
r
coeffici
given
confid
interv
ci
pvalu
consid
signific
start
studi
blood
ten
cat
pcrneg
haemof
cand
turicensi
howev
cat
becam
haemof
pcrposit
subcutan
haemof
exposur
crossprotect
haemof
observ
cat
previous
infect
cand
turicensi
cand
turicensi
detect
qpcr
analysi
blood
sampl
cat
cat
group
becam
haemof
pcrposit
day
exposur
control
cat
group
b
becam
pcrposit
day
figur
thu
cat
experienc
cand
turicensi
infect
becam
haemof
pcrposit
significantli
earlier
cat
pmwu
maximum
haemof
blood
load
similar
group
reach
copiesml
blood
cat
group
display
fairli
consist
high
copi
number
copiesml
start
day
persist
day
haemof
exposur
high
bacteri
load
copiesml
observ
later
infect
less
consist
cat
group
b
start
day
exposur
copi
number
fluctuat
throughout
cours
haemof
infect
observ
cat
pronounc
cat
group
b
copi
number
fluctuat
particularli
mark
cat
group
b
fourlog
fluctuat
within
four
day
figur
two
cat
group
three
cat
group
b
exhibit
transient
clinic
sign
hemoplasmosi
within
first
nine
week
subcutan
exposur
haemof
sever
outcom
observ
cat
group
b
figur
cat
last
cat
becom
pcrposit
present
studi
sever
clinic
sign
necessit
antibiot
treatment
describ
previous
briefli
cat
enlarg
abdomen
exhibit
pale
mucou
membran
apathi
anorexia
increas
saliv
four
cat
cat
depress
exhibit
pale
mucou
membran
reduc
appetit
period
day
treatment
requir
signific
deviat
bodi
temperatur
bodi
weight
observ
cat
cours
experi
five
cat
group
four
five
cat
group
b
develop
anemia
hematocrit
present
studi
figur
cat
group
previous
undergon
cand
turicensi
infect
display
onset
anemia
day
post
haemof
exposur
day
pcrposit
time
maxim
bacteremia
cat
although
one
cat
previous
slightli
transient
anem
minimum
hematocrit
day
exposur
figur
interestingli
four
five
cat
group
b
develop
anemia
onset
anemia
occur
significantli
later
cat
group
day
post
haemof
exposur
pmwu
lowest
singl
hematocrit
valu
among
cat
figur
cat
group
b
exhibit
signific
differ
time
hematocrit
addit
file
mark
asterisk
rbc
data
shown
decreas
red
blood
cell
valu
coincid
maxim
bacteremia
overal
hematocrit
significantli
correl
haemof
load
ps
r
ci
cat
group
also
display
signific
differ
time
erythrocyt
volum
mcv
addit
file
hemoglobin
concentr
erythrocyt
mchc
addit
file
alter
erythrocyt
indic
increas
mcv
decreas
mchc
coincid
maxim
bacteremia
anemia
indic
macrocyt
hypochrom
anemia
erythrocyt
indic
return
preexposur
valu
slowli
hematocrit
data
shown
cat
group
b
exhibit
increas
mcv
decreas
mchc
similar
cat
group
slightli
later
time
point
addit
file
f
none
cat
test
posit
coomb
test
time
point
test
late
infect
day
haemof
exposur
white
blood
cell
wbc
count
significantli
differ
group
b
day
signific
differ
time
observ
wbc
count
cat
group
cat
group
b
figur
e
low
wbc
count
mark
asterisk
howev
four
anem
cat
group
b
exhibit
leukopenia
sever
time
point
throughout
studi
neutropenia
observ
sever
cat
group
throughout
experi
occur
frequent
sever
cat
treat
due
sever
clinic
outcom
minim
neutrophil
count
day
remark
cat
group
higher
lymphocyt
count
cat
group
b
start
experi
day
pmwu
figur
f
signific
differ
time
lymphocyt
count
observ
group
figur
decreas
maxim
bacteremia
mark
asterisk
due
decreas
lymphocyt
count
group
differ
two
group
day
post
exposur
thereaft
cat
group
higher
lymphocyt
count
cat
group
b
addit
parallel
decreas
wbc
lymphocyt
count
signific
increas
monocyt
count
figur
decreas
eosinophil
count
figur
observ
cat
group
group
b
similar
alter
less
pronounc
observ
includ
increas
monocyt
figur
decreas
eosinophil
figur
although
cat
group
higher
total
lymphocyt
count
day
signific
differ
lymphocyt
subset
observ
time
point
figur
howev
cat
group
significantli
higher
cell
count
lymphocyt
count
activ
cell
b
cell
count
cat
group
b
sever
time
point
throughout
studi
cell
cell
higher
group
group
b
alreadi
within
day
haemof
exposur
b
cell
significantli
higher
group
compar
group
b
later
cours
infect
maxim
bacteremia
figur
b
c
e
differ
mark
asterisk
signific
differ
time
observ
cell
count
group
increas
valu
group
within
day
haemof
exposur
figur
mark
arrow
addit
cat
group
b
exhibit
signific
differ
time
activ
cell
count
also
within
day
haemof
exposur
figur
mark
arrow
significantli
decreas
lymphocyt
count
observ
group
onset
maxim
bacteremia
day
compar
later
time
point
figur
mark
arrow
b
cell
decreas
time
maxim
bacteremia
group
day
rebound
thereaft
figur
mark
arrow
final
ratio
significantli
fluctuat
time
clear
pattern
recogn
figur
compar
two
group
cat
group
significantli
higher
protein
albumin
globulin
concentr
cat
group
b
prior
haemof
exposur
day
pmwu
figur
addit
file
c
cat
group
exhibit
signific
increas
total
serum
protein
globulin
decreas
albumin
particularli
week
haemof
exposur
consist
maxim
bacteremia
cat
addit
file
c
cat
group
b
exhibit
tendenc
similar
less
pronounc
group
addit
file
h
globulin
concentr
significantli
higher
group
group
b
day
albumin
concentr
lower
day
post
exposur
pmwu
addit
file
serum
protein
electrophoresi
prior
haemof
exposur
reveal
cat
group
significantli
higher
valu
cat
group
b
pmwu
figur
signific
differ
time
observ
ten
cat
analyz
combin
figur
albumin
concentr
significantli
lower
concentr
significantli
higher
test
time
point
haemof
exposur
compar
preexposur
valu
figur
addit
file
g
nine
ten
cat
concentr
refer
rang
gl
day
figur
data
shown
albumin
globulin
ratio
significantli
decreas
three
test
time
point
haemof
exposur
compar
preexposur
valu
pw
data
shown
moreov
day
haemof
exposur
fraction
significantli
higher
compar
preexposur
valu
pw
data
shown
electrophoretogram
day
post
exposur
indic
polyclon
hypergammaglobulinemia
figur
cat
group
group
b
albeit
less
pronounc
exhibit
signific
differ
time
addit
clinic
chemistri
paramet
throughout
experi
mostli
week
haemof
exposur
consist
maxim
bacteremia
follow
deviat
observ
decreas
cholesterol
addit
file
creatinin
addit
file
k
alkalin
phosphatas
addit
file
sodium
addit
file
f
increas
bilirubin
addit
file
e
signific
invers
correl
observ
bilirubin
concentr
hematocrit
valu
ps
r
ci
cat
group
previous
experienc
cand
turicensi
infect
serolog
posit
begin
studi
addit
file
cat
display
remark
increas
antibodi
level
day
post
exposur
pw
significantli
higher
antibodi
level
cat
group
b
day
exposur
pmwu
addit
file
five
cat
group
b
seroneg
start
studi
elisa
signaltonois
ratio
addit
file
cat
seroconvert
seven
ten
day
blood
sampl
identifi
pcrposit
day
exposur
except
cat
seroconvert
day
haemof
exposur
seroconvers
occur
day
cat
transient
identifi
pcrposit
ten
day
onset
persist
pcrposit
cat
group
achiev
maximum
antibodi
product
significantli
earlier
acut
infect
day
post
exposur
cat
group
b
day
post
exposur
pmwu
maximum
antibodi
level
acut
infect
significantli
higher
group
group
b
pmwu
antibodi
level
significantli
correl
haemof
blood
load
ps
r
ci
similar
pattern
cytokin
transcript
level
observ
group
b
tendenc
alter
occur
later
group
b
group
figur
antiinflammatori
mrna
level
vari
significantli
time
group
higher
valu
time
maxim
bacteremia
compar
valu
earli
haemof
exposur
figur
c
indic
arrow
increas
mean
transcript
level
pronounc
group
day
day
increas
group
b
day
increas
increas
mean
transcript
level
pronounc
group
b
day
day
increas
group
day
increas
moreov
signific
decreas
level
observ
group
b
figur
signific
decreas
time
ratio
particularli
group
day
day
post
exposur
mean
decreas
ratio
ratio
particularli
group
b
observ
figur
h
contrast
mrna
level
significantli
increas
time
group
figur
signific
differ
time
observ
transcript
level
figur
f
b
signific
differ
observ
group
b
except
differ
day
figur
mark
asterisk
saliva
rectal
swab
collect
time
point
indic
figur
day
post
haemof
exposur
rectal
swab
cat
saliva
swab
eight
ten
cat
pcrposit
haemof
two
cat
group
b
test
saliva
swab
neg
figur
j
haemof
load
saliva
fece
copiesswab
posit
result
obtain
high
bacteremia
saliva
rectal
swab
collect
day
post
haemof
exposur
test
haemof
pcrneg
data
shown
urin
sampl
nine
ten
cat
test
pcrposit
haemof
cat
group
neg
four
occas
test
figur
haemof
load
urin
sampl
copiesml
urin
highest
haemof
load
urin
observ
sampl
high
erythrocyt
contamin
urinalysi
shed
urin
strictli
associ
high
blood
load
signific
correl
blood
urin
load
observ
ps
blood
contamin
urin
sampl
data
shown
remark
five
cat
becam
pcrneg
detect
haemof
blood
within
observ
period
without
antibiot
treatment
four
cat
group
cat
one
cat
group
b
remain
six
cat
still
pcrposit
end
studi
day
haemof
exposur
data
shown
present
studi
crossprotect
haemof
observ
five
cand
turicensi
recov
cat
contrast
cat
previous
infect
cand
turicensi
infect
exhibit
faster
onset
infect
becam
pcrposit
anem
significantli
earlier
haemofelisexpos
control
cat
moreov
cat
previous
infect
cand
turicensi
persist
high
haemof
bacteri
load
copiesml
higher
total
cell
cat
within
day
haemof
exposur
sever
possibl
explan
find
cand
turicensi
recov
cat
becam
haemof
pcrposit
significantli
earlier
cat
preexist
antibodi
hemoplasma
might
impact
kinet
haemof
infect
cat
recov
cand
turicensi
infect
eg
antibodydepend
enhanc
ade
ade
increas
replic
distribut
pathogen
particularli
virus
eg
felin
corona
viru
howev
ade
also
suspect
bacteri
infect
specif
antibodi
respons
streptococcu
pneumonia
enhanc
infect
specul
bacteri
enzym
modifi
specif
antibodi
bind
bacteria
target
cell
inhibit
augment
therebi
facilit
prolong
persist
bacteria
mucos
surfac
respiratori
tract
crossreact
antibodi
felin
hemoplasma
least
current
avail
recombin
haemof
antigen
dnak
demonstr
occurr
similar
phenomenon
cand
turicensi
recov
cat
high
antibodi
level
prior
haemof
exposur
exclud
altern
chronic
cand
turicensi
infect
cat
may
becom
haemof
pcrposit
earlier
cat
due
modul
downregul
immun
system
influenc
hemotrop
mycoplasma
infect
host
immun
system
yet
complet
elucid
nonhemotrop
mycoplasma
infect
multitud
mechan
describ
might
modul
downregul
cellmedi
andor
humor
immun
respons
infect
host
none
hypothes
howev
adequ
explain
observ
enhanc
heterolog
cand
turicensi
haemof
homolog
challeng
cand
turicensi
cand
turicensi
haemofel
haemof
base
immun
respons
hemoplasma
infect
respons
suspect
primari
haemof
infect
cat
primari
cand
turicensi
infect
cat
might
associ
earli
respons
subsequ
switch
cat
recov
cand
turicensi
infect
protect
reinfect
associ
earli
pronounc
respons
result
requir
confirm
respons
may
least
partial
contribut
lack
crossprotect
differ
infect
kinet
observ
present
studi
inde
cand
turicensi
infect
lead
stimul
humor
immun
respons
effect
might
counterproduct
subsequ
haemof
exposur
protect
observ
absenc
respons
start
studi
addit
seroposit
dnak
cand
turicensi
recov
cat
higher
total
lymphocyt
count
protein
albumin
concentr
control
cat
indic
immun
system
stimul
cand
turicensi
recov
cat
particular
increas
globulin
level
may
indic
predomin
humor
immun
respons
cat
thu
cand
turicensi
recov
cat
despit
even
due
observ
seroposit
statu
immun
system
may
illprepar
subsequ
haemof
exposur
consist
within
day
haemof
exposur
cand
turicensi
recov
cat
exhibit
higher
total
reactiv
tcell
count
control
cat
particularli
lymphocyt
lymphocyt
subset
differ
observ
cat
cand
turicensi
recov
cat
cand
turicensi
recov
cat
cat
show
transient
decreas
lymphocyt
subset
especi
b
cell
maxim
bacteremia
previou
studi
transient
decreas
lymphocyt
haemof
infect
attribut
cell
migrat
blood
drain
lymph
node
lymphocyt
becom
activ
prolif
increas
total
protein
concentr
suggest
b
cell
activ
high
bacteremia
increas
parallel
decreas
albumin
possibl
due
role
albumin
neg
acut
phase
protein
increas
total
protein
time
maxim
bacteremia
primarili
attribut
increas
product
immunoglobulin
demonstr
detect
polyclon
hypergammaglobulinemia
serum
protein
electrophoresi
sampl
obtain
nine
ten
cat
observ
hypergammaglobulinemia
coincid
high
specif
antibodi
haemof
determin
recombin
haemof
dnak
antigen
elisa
larg
proport
immunoglobulin
probabl
hemoplasmaspecif
reflect
polyclon
b
cell
activ
mitogen
activ
lymphocyt
nonspecif
polyclon
manner
well
describ
nonhemotrop
mycoplasma
mycoplasma
sui
porcin
hemoplasma
signific
alter
rbc
surfac
lead
upregul
natur
occur
b
cell
specif
selfantigen
induct
autoreact
igm
igg
turn
lead
extra
intravascular
hemolysi
previou
studi
demonstr
haemofelisinfect
cat
harbor
antibodi
direct
erythrocyt
surfac
coomb
test
posit
nadir
hematocrit
valu
time
maxim
bacteremia
current
studi
coomb
test
neg
test
perform
later
time
point
infect
b
cell
count
immunoglobulin
valu
return
preinfect
valu
sever
alter
clinic
chemistri
paramet
associ
high
haemof
blood
load
observ
decreas
cholesterol
alter
lipid
metabol
decreas
cholesterol
level
report
mani
infect
includ
viral
bacteri
parasit
infect
observ
decreas
cholesterol
concentr
present
studi
might
reflect
increas
need
cholesterol
membran
synthesi
either
larg
number
rbc
destroy
haemof
infect
andor
fast
amplif
hemoplasma
mycoplasma
depend
cholesterol
host
membran
synthesi
incorpor
larg
quantiti
cholesterol
membran
improv
membran
fluiditi
moreov
signific
increas
bilirubin
concentr
observ
time
point
previous
describ
acut
haemof
infect
may
lead
hemolyt
anemia
result
increas
bilirubin
concentr
present
studi
bilirubin
concentr
directli
associ
bacteri
load
may
support
causal
connect
cytokin
respons
observ
haemof
infect
present
studi
predominantli
type
consist
previou
result
cat
infect
haemof
present
studi
particularli
cand
turicensi
recov
cat
display
massiv
increas
transcript
level
approxim
coincid
appear
high
bacteri
load
effect
parallel
pronounc
decreas
ratio
alter
suggest
predomin
respons
group
establish
high
bacteri
load
cat
contrast
predomin
respons
high
transcript
level
high
ratio
increas
eosinophil
observ
cand
turicensi
infect
cat
high
cand
turicensi
bacteremia
consist
absenc
respons
eosinophilia
observ
present
studi
rather
decreas
eosinophil
observ
time
maxim
bacteremia
respons
postul
haemofelisinfect
cat
present
studi
might
first
glanc
contradict
major
increas
level
particularli
cat
also
observ
high
bacteri
load
increas
transcript
level
also
observ
previou
studi
cat
infect
haemof
cat
protect
haemof
reinfect
multipl
effect
inhibit
cell
may
associ
b
cell
prolifer
antibodi
product
thu
high
transcript
level
observ
time
high
bacteremia
would
consist
high
serum
protein
antim
haemof
dnak
antibodi
level
observ
time
howev
also
consid
potent
antiinflammatori
cytokin
may
limit
damag
host
due
exacerb
inflamm
prolong
pathogen
clearanc
therefor
hypothes
high
level
observ
maxim
bacteremia
haemofelisinfect
cat
previou
studi
might
limit
inflammatori
respons
haemof
potenti
prevent
clearanc
organ
whether
antiinflammatori
effect
benefici
bacteri
infect
sepsi
debat
unknown
high
antiinflammatori
level
observ
present
studi
associ
decreas
leukocyt
count
neutropenia
observ
high
bacteremia
among
hematolog
alter
leukocytosi
neutrophilia
characterist
inflamm
reduct
local
system
inflamm
connect
may
reflect
inhibit
cell
traffick
particularli
recruit
neutrophil
injuri
site
via
inhibit
product
neutrophil
chemoattract
measur
antibodi
haemof
cand
turicensi
recov
cat
display
earlier
higher
increas
antidnak
antibodi
cat
contrast
increas
antibodi
observ
cat
protect
homolog
reinfect
inde
cat
undergon
cand
turicensi
infect
transient
decreas
antibodi
observ
upon
homolog
cand
turicensi
reexposur
potenti
reflect
bind
antibodi
inocul
antigen
level
antibodi
observ
present
studi
respons
haemof
infect
higher
level
antibodi
report
cand
turicensi
infect
consist
result
previou
studi
use
similar
prepar
antigen
find
might
reflect
higher
blood
load
obtain
haemof
exposur
compar
cand
turicensi
use
dnak
haemof
cand
turicensi
antigen
elisa
shed
pattern
haemof
also
investig
present
studi
studi
first
report
shed
haemof
dna
saliva
fece
urin
posit
saliva
rectal
swab
obtain
high
bacteremia
infrequ
persist
find
might
explain
previou
studi
unabl
detect
haemof
saliva
salivari
gland
sampl
collect
one
time
point
late
infect
cat
moreov
haemof
load
observ
salivari
swab
hundr
copiesswab
present
studi
correspond
cand
turicensi
infect
cat
report
previou
studi
cand
turicensi
infect
cat
fairli
consist
shed
cand
turicensi
via
saliva
high
bacteremia
maxim
blood
load
lower
haemofelisinfect
cat
factor
blood
load
must
play
role
whether
felin
hemoplasma
shed
via
saliva
haemof
transmiss
studi
use
pcrposit
saliva
fece
conduct
transmiss
studi
perform
use
cand
turicensi
pcrposit
saliva
cat
demonstr
infect
oral
uptak
subcutan
inocul
cand
turicensi
pcrposit
saliva
present
studi
haemofelisposit
urin
sampl
also
observ
sampl
collect
cystocentesi
complet
exclud
contribut
erythrocyt
contamin
pcrposit
result
howev
haemof
pcrposit
result
also
detect
urin
sampl
erythrocyt
detect
use
urin
test
strip
sediment
analys
low
haemof
copi
number
saliva
fece
urin
sampl
haemofelisinfect
cat
infrequ
shed
even
high
bacteremia
suggest
minim
risk
transmiss
mutual
groom
share
feed
dish
litter
box
howev
confirm
futur
studi
conclus
contrast
homolog
challeng
protect
heterolog
haemof
challeng
observ
cat
recov
previou
cand
turicensi
infect
indic
cand
turicensi
probabl
good
candid
attenu
vaccin
pathogen
haemof
differ
immun
reaction
pattern
versu
cand
turicensi
haemof
infect
corrobor
studi
provid
first
evid
presenc
polyclon
hypergammaglobulinemia
cat
infect
felin
hemoplasma
moreov
recov
cat
higher
lymphocyt
count
final
studi
also
suggest
previou
hemoplasma
infect
even
cat
ostens
recov
may
influenc
subsequ
infect
potenti
lead
enhanc
phenomenon
differ
infect
kinet
